NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Contract (Products)
Duration
2 year
Value
£262M
Sector
HEALTH
Published
24 Jul 2025
Delivery
01 Sep 2025 to 31 Aug 2027
Deadline
18 Mar 2025 13:00

Concepts

Location

Geochart for 1 buyers and 28 suppliers

1 buyer

28 suppliers

Description

NHS Framework Agreement for Branded Medicines - Tranche A London and South of England and Adult Influenza (National) - 01 September 2025 Offer reference number: CM/PHR/24/5718 CM/PHR/24/5718/01 - NHS Framework Agreement for Branded Medicines - Tranche A for London and South of England. Period of Framework Agreement: 01 September 2025 to 31 August 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/24/5718/02 - NHS Framework Agreement for Branded Medicines - Adult Influenza (National). Period of Framework Agreement: 01 September 2025 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months.

Award Detail

1 Roche Products (None)
  • Value: £261,895,933
2 Amgen (None)
  • Value: £261,895,933
3 Seqirus (Point Market Street Maidenhead)
  • Value: £261,895,933
4 Biogen (Maidenhead)
  • Value: £261,895,933
5 Teva (None)
  • Value: £261,895,933
6 Drreddys Laboratories (Cambridge)
  • Value: £261,895,933
7 Orifarm (Breakspear Park Hemel Hempstead)
  • Value: £261,895,933
8 Pfizer (Tadworth)
  • Value: £261,895,933
9 Vifor Pharma (Maidenhead)
  • Value: £261,895,933
10 Accord (Whiddon Valley Barnstaple)
  • Value: £261,895,933
11 Sandoz (Western Road Bracknell)
  • Value: £261,895,933
12 Eli Lilly (Basingstoke)
  • Value: £261,895,933
13 Chugai Pharma (None)
  • Value: £261,895,933
14 Mylan (Hatfield)
  • Value: £261,895,933
15 Aventis Pharma (Reading)
  • Value: £261,895,933
16 Manx Healthcare (None)
  • Value: £261,895,933
17 Janssen Cilag (High Wycombe)
  • Value: £261,895,933
18 Novo Nordisk (Gatwick)
  • Value: £261,895,933
19 Sun Pharma (Uxbridge)
  • Value: £261,895,933
20 Merck Serono (Feltham)
  • Value: £261,895,933
21 Bayer (Reading)
  • Value: £261,895,933
22 Napp Pharmaceuticals (Milton)
  • Value: £261,895,933
23 Astrazeneca (London)
  • Value: £261,895,933
24 CST Pharma (Walsall)
  • Value: £261,895,933
25 Pharmacosmos (Reading)
  • Value: £261,895,933
26 Thornton & Ross (Huddersfield)
  • Value: £261,895,933
27 Glaxosmithkline (London)
  • Value: £261,895,933
28 Gedeon Richter (London)
  • Value: £261,895,933

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

CM_PHR_24_5718_01 - Tranche A - London & South of England - Transparency Award Schedule#2 CM_PHR_24_5718_01 - Tranche A - London & South of England - Transparency Award Schedule#2.pdf CM_PHR_24_5718_02 - Tranche A - Adult Influenza National - Transparency Award Schedules#2 CM_PHR_24_5718_02 - Tranche A - Adult Influenza National - Transparency Award Schedules#2.pdf

Reference

Domains